This HTML5 document contains 211 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1073/
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34156417
rdf:type
wikibase:Item
schema:description
vitenskapelig artikkel научна статия artigo científico наукова стаття, опублікована в серпні 2002 2002年論文 2002年论文 2002년 논문 บทความทางวิทยาศาสตร์ bài báo khoa học мақолаи илмӣ 2002年论文 tudományos cikk 2002年论文 vědecký článek artigo científico (publicado na 2002) article scientifique (publié 2002) vedecký článok teaduslik artikkel mokslinis straipsnis مقالهٔ علمی tieteellinen artikkeli bilimsel makale artículu científicu espublizáu en 2002 wetenschappelijk artikel artikulong pang-agham επιστημονικό άρθρο სამეცნიერო სტატია 2002年論文 научная статья articol științific scienca artikolo 2002年論文 article scientific artykuł naukowy vetenskaplig artikel 2002 թվականի օգոստոսին հրատարակված գիտական հոդված article científic 2002年の論文 2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած 2002年论文 wissenschaftlicher Artikel سائنسی مضمون мақолаи илмӣ videnskabelig artikel (udgivet 2002) articolo scientifico artigo científico (publicado na 2002) 2002年论文 2002 nî lūn-bûn مقالة علمية 2002年论文 scientific article научни чланак vitskapeleg artikkel naučni članak научни чланак ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2002年論文 artículo científico publicado en 2002 artikull shkencor מאמר מדעי 2002年論文
p:P577
wds:Q34156417-572E86DB-E235-4FA0-ADCE-EEEDDCC601BB
wdt:P577
2002-08-30T00:00:00Z
p:P407
wds:Q34156417-0AF8A64D-2E0A-4942-9BED-29070C02B022
wdt:P407
wd:Q1860
p:P2860
wds:Q34156417-F25C25DB-E457-4A1D-A593-A5E137236E28 wds:Q34156417-F6791FE8-412C-4516-8A54-7962661DF449 wds:Q34156417-F6F9A00A-6AE9-4B97-BF6B-EB7720778885 wds:Q34156417-F84A6140-1419-428D-B2D1-F2CFABF4E8B4 wds:Q34156417-EE117412-23E4-4C0E-B894-1BFE835DF644 wds:Q34156417-F8913E99-5C12-4099-8BD8-D0AB81C0454E wds:Q34156417-FA89E0FD-26B4-4B18-BF23-4BDB40FA3ED8 wds:Q34156417-FDEDFD9B-ADF2-4996-A122-8C94BC2FC8C9 wds:Q34156417-C98784CC-AAD8-4DD3-8761-CD2F51A4E2DB wds:Q34156417-B17E3160-7C11-4A01-8947-C72B187DA3F4 wds:Q34156417-B394E784-C07B-4CF5-A9BE-164CC2A2046D wds:Q34156417-BD1C3F85-870A-45BE-BED1-53842E1EF230 wds:Q34156417-BD3E3120-AAD9-4D49-9D5A-090D28DEF4DB wds:Q34156417-E62446B6-F745-4261-8B50-A27E5943576B wds:Q34156417-E6795519-FAFF-4E5F-91EC-B511AD72E342 wds:Q34156417-E9926CBA-853B-468D-BC01-1713E167EF9B wds:Q34156417-D63976D1-F8D8-4100-A98C-4DAB357D09F3 wds:Q34156417-D8B57FEF-70C4-48C7-A515-0C035C945A67 wds:Q34156417-E2CF6E54-05C8-479C-8938-046C92F52287 wds:Q34156417-E4ABE19A-9B36-4ECA-A41D-0A29856F5A30 wds:Q34156417-75A26C2F-C54E-49FF-95EC-C5B8DBB9D9E4 wds:Q34156417-80D72361-D7FA-49C6-908D-BF80527B64A7 wds:Q34156417-5A0ED3C0-B4C2-46BA-923C-8FC3FCAD7955 wds:Q34156417-5DA92321-54C5-449F-8CBA-4A5F147E8916 wds:Q34156417-6867B242-97B5-4E4E-B974-6B8596A23DDD wds:Q34156417-6B42C3B4-E5EF-4F3D-BB13-360E69006CB0 wds:Q34156417-9A4CB1AD-5021-4607-AFE7-A86CC700CB36 wds:Q34156417-A1556672-E09C-41DD-89AF-4B8F03C0D6DB wds:Q34156417-AC4DFA70-B852-45E1-AB08-56DA74CCF567 wds:Q34156417-328512D6-B495-4A38-A01A-39910AD38CA1 wds:Q34156417-34BB17C0-37F2-4730-AB2F-95B731AF2C53 wds:Q34156417-205D70A9-9A43-4112-9F2F-22A57E7EC84B wds:Q34156417-2A8B837F-7E58-40EB-8E86-A1DCEE6CF1AF wds:Q34156417-458BB2C2-32CA-4355-AC93-9F9523F829DB wds:Q34156417-4DF87B0B-C645-4A53-A285-08FE1C3A4E6F wds:Q34156417-58A95DF0-0EFE-43EA-8F88-63C10A1FB026 wds:Q34156417-39544016-0DCD-4911-BB6B-C025D45B0BF9 wds:Q34156417-3E35C9BC-66C3-4D97-9DBD-D78F47C11D2E wds:Q34156417-066AE991-EEBC-46F9-B053-1294AB3C139A wds:Q34156417-14AAFBAB-2C46-4CA7-9E4B-1BE1B0A2836C wds:Q34156417-1802931E-47EA-4FC5-88BE-21E0CA659343 wds:Q34156417-180DA2D9-80D1-4EE5-8064-98999DC0CB15 wds:Q34156417-077EEA03-4EC9-4AAA-9AE1-BEF117494431 wds:Q34156417-090313BB-F4EB-47BF-A471-D5ADE0C4545F wds:Q34156417-0F1FD5CB-CA9E-4B2B-8AD3-9E6A48140F88
wdt:P2860
wd:Q34627840 wd:Q52705767 wd:Q51877094 wd:Q73693921 wd:Q53559861 wd:Q38294681 wd:Q33912397 wd:Q74088453 wd:Q34478991 wd:Q40370722 wd:Q33745932 wd:Q43657329 wd:Q41022793 wd:Q53557658 wd:Q77088265 wd:Q95721661 wd:Q47299337 wd:Q37854924 wd:Q43691451 wd:Q53405861 wd:Q40752051 wd:Q77881866 wd:Q73699282 wd:Q41012808 wd:Q43932143 wd:Q41733286 wd:Q29303363 wd:Q51855312 wd:Q53569892 wd:Q45819736 wd:Q71607063 wd:Q68411876 wd:Q34308225 wd:Q74241171 wd:Q67520346 wd:Q34099655 wd:Q41040593 wd:Q34504013 wd:Q42524762 wd:Q67280976 wd:Q59073226 wd:Q52536369 wd:Q41350125 wd:Q74163248 wd:Q68961888
p:P2093
wds:Q34156417-93194905-AF2E-4564-8CBB-F2CE9C40B459 wds:Q34156417-BE6D79D0-946C-4496-989B-9447EA3C6D5E wds:Q34156417-C5B8F20B-6329-4FAA-B6FA-DBFDEF33F494 wds:Q34156417-ED52914A-B065-4C40-8759-38F45DFC2CA7 wds:Q34156417-0499AA15-DFCC-495C-9C0B-4D67D4AA6504 wds:Q34156417-2953194A-9C0B-40CC-B23A-6BE38184EC90 wds:Q34156417-2F9172F0-2FBD-42F0-B54C-8683CDC4176D wds:Q34156417-3AC8D123-EE26-4E97-AEFA-7D9979C1ADBC
wdt:P2093
Chung S Yang Qing-Yun Peng Mou-Tuan Huang You-Rong Lou Jie Liao Yao-Ping Lu Jian-Guo Xie Allan H Conney
rdfs:label
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice Topical applications of caffeine or Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice
skos:prefLabel
Topical applications of caffeine or Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice
schema:name
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice Topical applications of caffeine or
p:P1476
wds:Q34156417-AFAC7B14-206E-4B5E-BC46-3E20D0AF88A4
wdt:P1476
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice
p:P304
wds:Q34156417-3035B824-9A82-483A-96AD-E88ABDBE844F
wdt:P304
12455-12460
p:P31
wds:Q34156417-7014D0F5-8EC5-4696-8610-DE4C672E7642
wdt:P31
wd:Q13442814
p:P921
wds:Q34156417-CB9569FD-9FBB-4EE2-8C66-C33AA36FD73D wds:Q34156417-9708BB63-42D2-4118-A28C-CB32AACBF4D8
wdt:P921
wd:Q1637543 wd:Q14599311
p:P698
wds:Q34156417-93A648E5-291B-4041-8ADD-6C173E964290
wdtn:P698
n10:12205293
wdt:P698
12205293
p:P1433
wds:Q34156417-39462902-D606-468A-9202-B040369046EC
wdt:P1433
wd:Q1146531
p:P433
wds:Q34156417-F06E92E9-9846-43AD-953B-EF5609707F95
p:P478
wds:Q34156417-1EDBBD7E-6FE1-4207-A0EA-F6DCC978A788
wdt:P433
19
wdt:P478
99
p:P356
wds:Q34156417-9637D627-ACF7-4277-B3D3-5733F280C9ED
wdtn:P356
n12:PNAS.182429899
wdt:P356
10.1073/PNAS.182429899
p:P8608
wds:Q34156417-6C4D09F3-8B48-4716-A057-84C1F2FFCD34
wdt:P8608
release_tmeqz2uvznggzlfnmqee37mxwi
p:P5875
wds:Q34156417-F1C07244-0739-4D41-9008-5C0CFD9023F4
wdt:P5875
11184028
p:P819
wds:Q34156417-ECBD97F0-CEDC-44D0-8E24-5BABABC94644
wdt:P819
2002PNAS...9912455L
p:P932
wds:Q34156417-174A9BDE-54FD-48A9-8E8E-F9B049F59A83
wdt:P932
129466